100s of titles, one news app for just $10 a month.
Latest Business news:
Meta asks to be spared tighter rules in Australia, saying iPhone’s tracking blocker is hurting business
Company tells consumer watchdog it is set to lose $10bn this year in wake of Apple iOS feature hampering ability…
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
Business investment expected to pick up
Economists expect figures will show business investment picked up further in the March quarter, providing a boost to growth in…
Woolworths brings in more cameras amid suspected rise in shoplifting
Supermarket giant Woolworths has installed cameras above self-service checkouts at select stores amid fears about a rise in shoplifting.
Super co-contribution has cost $10 billion to help the wrong Australians – so let's scrap it
Concerned that many people won’t have enough retirement savings even with compulsory superannuation, since 2003 the Australian government has had…
Terra Blockchain to Split, Abandon Collapsed UST Stablecoin
A proposal by the founder of the troubled Terra ecosystem to salvage the project was approved, averting a total collapse…
From analysis to good news, read the world’s best news in one place
Jack Dorsey leaves Twitter's board of directors
Dorsey signaled his plans last fall.
Google Takes Yet Another Run at E-Commerce—and Amazon
The search giant abandoned plans to mimic the Seattle-based leviathan and has reset its shopping strategy around search and ads.

Clearside Biomedical: Q1 Earnings Insights

By Benzinga Insights

Clearside Biomedical (NASDAQ:CLSD) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Clearside Biomedical missed estimated earnings by 62.5%, reporting an EPS of $-0.13 versus an estimate of $-0.08.

Revenue was up $313.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.15 which was followed by a 42.59% increase in the share price the next day.

Here's a look at Clearside Biomedical's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate 0.16 -0.08 -0.12 -0.10
EPS Actual 0.31 -0.08 -0.11 -0.13
Revenue Estimate 17.77M 2.58M 690.00K 2.12M
Revenue Actual 25.69M 3.07M 780.00K 34.00K

To track all earnings releases for Clearside Biomedical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.